Due to limited end-of-life discussions and the absence of palliative care, hospitalisations are frequent at the end of life among nursing home residents in Singapore, resulting in high health-care costs.
Aim:
Our objective was to evaluate the economic impact of Project Care at the End-of-Life for Residents in homes for the Elderly (CARE) programme on nursing home residents compared to usual end-of-life care.
Design and settings/participants:
Project CARE was introduced in seven nursing homes to provide advance care planning and palliative care for residents identified to be at risk of dying within 1 year. The cases consisted of nursing home residents enrolled in the Project CARE programme for at least 3 months. A historical group of nursing home residents not in any end-of-life care programme was chosen as the matched controls. Cost differences between the two groups were analysed over the last 3 months and final month of life.
Results:
The final sample comprised 48 Project CARE cases and 197 controls. Compared to the controls, the cases were older with more comorbidities and higher nursing needs. After risk adjustment, Project CARE cases demonstrated per-resident cost savings of SGD$7129 (confidence interval: SGD$4544–SGD$9714) over the last 3 months of life and SGD$3703 (confidence interval: SGD$1848–SGD$5557) over the last month of life (US$1 = SGD$1.3).
Conclusion:
This study demonstrated substantial savings associated with an end-of-life programme. With a significant proportion of the population in Singapore requiring nursing home care in the near future, these results could assist policymakers and health-care providers in decision-making on allocation of health-care resources.
WerblowAFelderSZweifelP. Population ageing and health care expenditure: a school of ‘red herrings’?Health Econ2007; 16: 1109–1126.
2.
GrayA. Population ageing and health care expenditure. Ageing Horizons, 2005, pp. 15–20.
3.
ZweifelPFelderSMeiersM. Ageing of population and health care expenditure: a red herring?Health Econ1999; 8: 485–496.
4.
EmanuelEJ. Cost savings at the end of life. What do the data show?JAMA1996; 275: 1907–1914.
5.
LubitzJDRileyGF. Trends in Medicare payments in the last year of life. New Engl J Med1993; 328: 1092–1096.
6.
PolderJJBarendregtJJvan OersH. Health care costs in the last year of life – the Dutch experience. Soc Sci Med; 2006; 63: 1720–1731.
7.
BrumleyRDEnguidanosSCherinDA. Effectiveness of a home-based palliative care program for end-of-life. J Palliat Med2003; 6: 715–724.
8.
AxelssonBChristensenSB. Evaluation of a hospital-based palliative support service with particular regard to financial outcome measures. Palliat Med1998; 12: 41–49.
9.
JungHMKimJHeoDS. Health economics of a palliative care unit for terminal cancer patients: a retrospective cohort study. Support Care Cancer20: 29–37.
10.
BrumleyREnguidanosSJamisonP. Increased satisfaction with care and lower costs: results of a randomized trial of in-home palliative care. J Am Geriatr Soc2007; 55: 993–1000.
11.
Serra-PratMGalloPPicazaJM. Home palliative care as a cost-saving alternative: evidence from Catalonia. Palliat Med2001; 15: 271–278.
12.
SimoensSKuttenBKeirseE. Terminal patients in Belgian nursing homes: a cost analysis. Eur J Health Econ2013; 14: 407–413.
13.
PhillipsDR. Ageing in the Asia-Pacific region: issues, policies and future trends. London: Routledge, 2002, pp. 176–177.
YapLKAuSYAngYH. Who are the residents of a nursing home in Singapore?Singapore Med J2003; 44: 65–73.
16.
WrightMHamzahEPhungrassamiT. Hospice and palliative care in Southeast Asia: a review of developments and challenges in Malaysia, Thailand and the Philippines. Oxford: Oxford University Press, 2010, pp. 4–5.
17.
NeoPPoonMCPehTY. Improvements in end-of-life care with a protocol-based pathway for cancer patients dying in a Singapore hospital. Ann Acad Med Singapore41: 483–493.
18.
PhuaJKeeACTanA. End-of-life care in the general wards of a Singaporean hospital: an Asian perspective. J Palliat Med14: 1296–1301.
19.
KohNYKooWH. Polypharmacy in palliative care: can it be reduced?Singapore Med J2002; 43: 279–283.
20.
SeahSTLowJAChanYH. Symptoms and care of dying elderly patients in an acute hospital. Singapore Med J2005; 46: 210–214.
DumontSJacobsPFassbenderK. Costs associated with resource utilization during the palliative phase of care: a Canadian perspective. Palliat Med2009; 23: 708–717.
23.
NgRChanSNgTW. An exploratory study of the knowledge, attitudes and perceptions of advance care planning in family caregivers of patients with advanced illness in Singapore. BMJ Support Palliat Care2013; 3: 343–348.
24.
ChaterKTsaiCT. Palliative care in a multicultural society: a challenge for western ethics. Aust J Adv Nurs2008; 26: 95–100.
25.
WrightAAZhangBRayA. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA2008; 300: 1665–1673.
26.
MolloyDWGuyattGHRussoR. Systematic implementation of an advance directive program in nursing homes: a randomized controlled trial. JAMA2000; 283: 1437–1444.
27.
WeeNTWengSCHuatLLE. Advance care planning with residents in nursing homes in Singapore. Asia Pac J Soc Work2011: 21: 97–104.
28.
HickmanSENelsonCAMossAH. Use of the Physician Orders for Life-Sustaining Treatment (POLST) paradigm program in the hospice setting. J Palliat Med2009; 12: 133–141.
29.
GozaloPLMillerSCIntratorO. Hospice effect on government expenditures among nursing home residents. Health Serv Res2008; 43: 134–153.
30.
HickmanSENelsonCAPerrinNA. A comparison of methods to communicate treatment preferences in nursing facilities: traditional practices versus the Physician Orders for Life-Sustaining Treatment program. J Am Geriatr Soc2010; 58: 1241–1248.
Von ElmEAltmanDGEggerM. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med2007; 45: 247–251.
33.
CohenJDL. A public health perspective on end of life care. Oxford: Oxford University Press, 2012, p. 62.
34.
ShahSVanclayFCooperB. Improving the sensitivity of the Barthel Index for stroke rehabilitation. J Clin Epidemiol1989; 42: 703–709.
35.
LynnJSchallMWMilneC. Quality improvements in end of life care: insights from two collaboratives. Jt Comm J Qual Improv2000; 26: 254–267.
36.
MamunKLimJ. Use of physical restraints in nursing homes: current practice in Singapore. Ann Acad Med Singapore2005; 34: 158–162.
37.
NgMJM. Delivery of Integrated Care. The Singapore Family Physician2011; 37: 8.
38.
RobinsJMMÃn HernánBrumbackB. Marginal structural models and causal inference in epidemiology. Epidemiology2000; 11: 550–560.
39.
JonesAM. Applied econometrics for health economists: a practical guide. Oxford: Radcliffe Publishing, 2007, p. 47.
40.
GlickHADoshiJASonnadSS. Economic evaluation in clinical trials. Oxford: Oxford University Press, 2007, p. 110.
41.
BriggsAHWonderlingDEMooneyCZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ1997; 6: 327–340.
42.
EfronBTibshiraniR. An introduction to the bootstrap. Florida: CRC Press, 1993.
43.
WetleTShieldRTenoJ. Family perspectives on end-of-life care experiences in nursing homes. Gerontologist2005; 45: 642–650.
44.
StevensonDGBramsonJS. Hospice care in the nursing home setting: a review of the literature. J Pain Symptom Manage2009; 38: 440–451.
45.
OsmanIMGoddenDJFriendJA. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax1997; 52: 67–71.
46.
Rodriguez-ArtalejoFGuallar-CastillonPPascualCR. Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure. Arch Intern Med2005; 165: 1274–1279.
British Medical Association. Revisions to the GMS contract 2006/07. Delivering investment in general practice. London: British Medical Association, 2006.
